FOXO4-DRI FOXO4

An experimental peptide that dramatically reversed signs of aging in old mice by disrupting a process that keeps damaged cells alive. It has never been tested in humans, so whether the striking mouse results would hold up in people, safely, is completely unknown.

Also known as FOXO4-DRI peptide

Effects Longevity

Routes Subcutaneous

Legal status Research chemical

WADA Not listed

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose Not established for humans

Reported range Animal studies: intraperitoneal doses in the low mg/kg range

Route Injection (studied only in animals)

Frequency Not established

Duration Not established

An experimental senolytic peptide with striking results in mouse studies only; no human clinical trials exist, and self-sourced human use is entirely unstudied and unsupervised.

Where this comes from Animal studies only

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.